Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | EVP, Regional Businesses | March 04, 2026 | March 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QUEST DIAGNOSTICS INC
Report date March 04, 2026 · Filed March 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 67,122 |
Ending reported balance
After 2026-03-05 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-03-04 · Grant · Acquired 11,364 · Balance 78,486 F1: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Row 2 · 2026-03-04 · Tax withholding · Disposed 5,806 · Balance 72,680 F2: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. Row 3 · 2026-03-05 · Sale · Disposed 5,558 · Balance 67,122 F3: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. |
| Common StockSEC Table I · non-derivative | Indirect401(k)/SDCP | 4,502 |
Reported balance
Holding disclosure · report date 2026-03-04 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 4,502 F4: These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. |
Filing footnotes · ownership attribution and instrument terms
F1: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d).
F2: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award.
F3: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.
F4: These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 05, 2026 Filed Mar 6, 2026 21:45 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 5,558 | $206.21 | $1,146,115.18 |
DisclosureSEC source: 0001022079-26-000031 · wk-form4_1772833501.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,122 F3 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:45 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 5,806 | $204.86 | $1,189,417.16 |
DisclosureSEC source: 0001022079-26-000031 · wk-form4_1772833501.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 72,680 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:45 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 11,364 | $204.86 | $2,328,029.04 |
DisclosureSEC source: 0001022079-26-000031 · wk-form4_1772833501.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,486 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance stock award approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 21:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 632 | $207.73 | $131,285.36 |
DisclosureSEC source: 0001022079-26-000024 · wk-form4_1772660351.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,122 F2 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 648 | $204.86 | $132,749.28 |
DisclosureSEC source: 0001022079-26-000024 · wk-form4_1772660351.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,754 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 19, 2026 Filed Feb 20, 2026 22:11 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,433 | $204.83 | $293,521.39 |
DisclosureSEC source: 0001520897-26-000003 · wk-form4_1771625472.xml · nonDerivative · entry 4 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,402 F3 · shares: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:11 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 13,514 | $0.00 Strike: $204.96 | $0.00 |
DisclosureSEC source: 0001520897-26-000003 · wk-form4_1771625472.xml · derivative · entry 6 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,514 Underlying: Common Stock · 13,514 shares Expires 2036-02-18 F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:11 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 728 | $206.99 | $150,688.72 |
DisclosureSEC source: 0001520897-26-000003 · wk-form4_1771625472.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,835 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:11 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 433 | $210.01 | $90,934.33 |
DisclosureSEC source: 0001520897-26-000003 · wk-form4_1771625472.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,563 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 22:11 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 2,928 | $0.00 | $0.00 |
DisclosureSEC source: 0001520897-26-000003 · wk-form4_1771625472.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,996 F1 · security: Represents an award of restricted stock units. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 26,165 | $112.17 Strike: $112.17 | $2,934,928.05 |
DisclosureSEC source: 0001022079-26-000009 · wk-form4_1771364252.xml · derivative · entry 8 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,165 shares Expires 2030-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F8 · derivative.exercise_date: The options vested in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 351 | $209.10 | $73,394.94 |
DisclosureSEC source: 0001022079-26-000009 · wk-form4_1771364252.xml · nonDerivative · entry 6 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,068 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F6 · price: This transaction was executed in multiple trades at prices ranging from $208.970 to $209.355. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,619 | $208.21 | $337,093.12 |
DisclosureSEC source: 0001022079-26-000009 · wk-form4_1771364252.xml · nonDerivative · entry 5 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,419 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F5 · price: This transaction was executed in multiple trades at prices ranging from $207.810 to $208.600. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 3,500 | $207.08 | $724,787.70 |
DisclosureSEC source: 0001022079-26-000009 · wk-form4_1771364252.xml · nonDerivative · entry 4 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,038 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F4 · price: This transaction was executed in multiple trades at prices ranging from $206.770 to $207.675. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 10,122 | $206.37 | $2,088,883.21 |
DisclosureSEC source: 0001022079-26-000009 · wk-form4_1771364252.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,538 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F3 · price: This transaction was executed in multiple trades at prices ranging from $205.770 to $206.7489. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 10,573 | $205.21 | $2,169,655.73 |
DisclosureSEC source: 0001022079-26-000009 · wk-form4_1771364252.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,660 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $204.745 to $205.740. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 26,165 | $112.17 | $2,934,928.05 |
DisclosureSEC source: 0001022079-26-000009 · wk-form4_1771364252.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| March 05, 2025 Filed Mar 8, 2025 00:23 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 5,370 | $174.13 | $935,078.10 |
DisclosureSEC source: 0001022079-25-000094 · wk-form4_1741393392.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,068 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 5,010 | $173.74 | $870,437.40 |
DisclosureSEC source: 0001022079-25-000091 · wk-form4_1741210674.xml · nonDerivative · entry 4 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,438 F4 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance stock award. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 10,380 | $173.74 | $1,803,421.20 |
DisclosureSEC source: 0001022079-25-000091 · wk-form4_1741210674.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,448 F3 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 21:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 716 | $175.79 | $125,865.64 |
DisclosureSEC source: 0001022079-25-000091 · wk-form4_1741210674.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,068 F2 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 394 | $173.74 | $68,453.56 |
DisclosureSEC source: 0001022079-25-000091 · wk-form4_1741210674.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,784 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 27, 2025 Filed Feb 28, 2025 21:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 824 | $172.61 | $142,230.64 |
DisclosureSEC source: 0001022079-25-000071 · wk-form4_1740778491.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,178 F2 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| February 26, 2025 Filed Feb 28, 2025 21:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 455 | $171.75 | $78,146.25 |
DisclosureSEC source: 0001022079-25-000071 · wk-form4_1740778491.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,002 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 21:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 899 | $170.99 | $153,720.01 |
DisclosureSEC source: 0001022079-25-000052 · wk-form4_1740174056.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,457 F2 · kind: This sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| February 19, 2025 Filed Feb 21, 2025 21:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 535 | $169.71 | $90,794.85 |
DisclosureSEC source: 0001022079-25-000052 · wk-form4_1740174056.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,356 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 13,344 | $0.00 Strike: $165.30 | $0.00 |
DisclosureSEC source: 0001022079-25-000033 · wk-form4_1739572041.xml · derivative · entry 3 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,344 Underlying: Common Stock · 13,344 shares Expires 2035-02-12 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 3,479 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-25-000033 · wk-form4_1739572041.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,891 F1 · security: Represents an award of restricted stock units. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 33,103 | $103.57 Strike: $103.57 | $3,428,477.71 |
DisclosureSEC source: 0001022079-24-000206 · wk-form4_1733175712.xml · derivative · entry 5 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,103 shares Expires 2028-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 28,300 | $163.13 | $4,616,709.18 |
DisclosureSEC source: 0001022079-24-000206 · wk-form4_1733175712.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,412 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F3 · price: This transaction was executed in multiple trades at prices ranging from $162.815 to $163.790. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 4,803 | $162.14 | $778,775.23 |
DisclosureSEC source: 0001022079-24-000206 · wk-form4_1733175712.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,712 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. F2 · price: This transaction was executed in multiple trades at prices ranging from $161.790 to $162.785. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 27, 2024 Filed Dec 2, 2024 21:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Exercise / conversionCommon Stock | 33,103 | $103.57 | $3,428,477.71 |
DisclosureSEC source: 0001022079-24-000206 · wk-form4_1733175712.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,515 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| February 29, 2024 Filed Mar 1, 2024 21:51 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,187 | $125.88 | $149,419.56 |
DisclosureSEC source: 0001022079-24-000084 · wk-form4_1709329881.xml · nonDerivative · entry 4 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,412 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:51 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 5,557 | $126.57 | $703,349.49 |
DisclosureSEC source: 0001022079-24-000084 · wk-form4_1709329881.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,599 F2 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:51 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 557 | $126.36 | $70,382.52 |
DisclosureSEC source: 0001022079-24-000084 · wk-form4_1709329881.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,156 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 28, 2024 Filed Mar 1, 2024 21:51 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 644 | $126.36 | $81,375.84 |
DisclosureSEC source: 0001022079-24-000084 · wk-form4_1709329881.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 75,713 F1 · shares: Sale of common stock to satisfy tax obligations arising from the vesting of a previous grant of restricted share units. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 3,757 | $125.02 | $469,700.14 |
DisclosureSEC source: 0001022079-24-000064 · wk-form4_1709069583.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,357 F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| February 23, 2024 Filed Feb 27, 2024 21:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 9,314 | $125.02 | $1,164,436.28 |
DisclosureSEC source: 0001022079-24-000064 · wk-form4_1709069583.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,114 F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2021, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 21:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 821 | $126.14 | $103,560.94 |
DisclosureSEC source: 0001022079-24-000050 · wk-form4_1708723905.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,800 F2 · kind: This sale reported wase effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 21:32 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 493 | $125.02 | $61,634.86 |
DisclosureSEC source: 0001022079-24-000050 · wk-form4_1708723905.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · EVP, Regional Businesses 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,621 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 01:01 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 17,939 | $0.00 Strike: $127.81 | $0.00 |
DisclosureSEC source: 0001022079-24-000029 · wk-form4_1708131707.xml · derivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,939 Underlying: Common Stock · 17,939 shares Expires 2034-02-14 F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 14, 2024 Filed Feb 17, 2024 01:01 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 4,304 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-24-000029 · wk-form4_1708131707.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,114 F1 · security: Represents an award of restricted share units. Read SEC document |
| March 07, 2023 Filed Mar 8, 2023 21:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 5,307 | $140.55 | $745,898.85 |
DisclosureSEC source: 0001022079-23-000069 · wf-form4_167831147773831.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,810 F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 27, 2022. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 4,610 | $147.86 | $681,634.60 |
DisclosureSEC source: 0001022079-23-000069 · wf-form4_167831147773831.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,117 F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 06, 2023 Filed Mar 8, 2023 21:38 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 9,917 | $147.86 | $1,466,327.62 |
DisclosureSEC source: 0001022079-23-000069 · wf-form4_167831147773831.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,727 F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2020, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 22:08 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 717 | $140.63 | $100,831.71 |
DisclosureSEC source: 0001022079-23-000054 · wf-form4_167814051080087.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,810 F1 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 27, 2022. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | Tax withholdingCommon Stock | 392 | $140.69 | $55,150.48 |
DisclosureSEC source: 0001022079-23-000042 · wf-form4_167787941666016.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,527 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. Read SEC document |
| February 27, 2023 Filed Feb 27, 2023 21:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantNon-Qualifed Stock Option (right to buy) · Derivative | 15,167 | $0.00 Strike: $143.33 | $0.00 |
DisclosureSEC source: 0001022079-23-000030 · wf-form4_167753410682903.xml · derivative · entry 5 Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,167 Underlying: Common Stock · 15,167 shares Expires 2033-02-23 F5 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 24, 2023 Filed Feb 27, 2023 21:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,690 | $141.42 | $238,999.80 |
DisclosureSEC source: 0001022079-23-000030 · wf-form4_167753410682903.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,919 F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 27, 2022. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 3,838 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-23-000030 · wf-form4_167753410682903.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Regional Businesses 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,609 F2 · security: Represents an award of restricted share units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.